1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow LSN3172176: new trials by email Literature Review of LSN3172176 trials Research Report on LSN3172176
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor Scopolamine, [11C]EMO ([11C]LSN3172176) - Muscarinic Receptor Occupancy | Phase 1 | Withdrawn | Yale University | 2025-03-01 | 2025-05-11 |
Yale University (1)
United States (1)